Cetirizine

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Name /bks_53161_deglins_md_disk/cetirizine 02/11/2014 09:37AM Plate # 0-Composite pg 1 # 1

1 Adverse Reactions/Side Effects


CNS: dizziness, drowsiness (significant with doses ⬎10 mg/day), fatigue. EENT: PDF Page #1
cetirizine (se-ti-ra-zeen) pharyngitis. GI: dry mouth.
Aller Relief, Reactine, ZyrTEC Interactions
Classification Drug-Drug: Additive CNS depression may occur with alcohol, opioid analge-
Therapeutic: allergy, cold, and cough remedies, antihistamines sics, or sedative/hypnotics. Theophylline maypclearance andqtoxicity.
Pharmacologic: piperazines (peripherally selective)
Pregnancy Category B Route/Dosage
PO (Adults and children ⱖ6 yr): 5– 10 mg given once or divided twice daily.
PO (Children 2– 5 yr): 2.5 mg once daily initially, may beqto 5 mg once daily or
Indications 2.5 mg every 12 hr.
Relief of allergic symptoms caused by histamine release including: Seasonal and pe- PO (Children 1– 2 yr): 2.5 mg once daily; may beqto 2.5 mg every 12 hr.
rennial allergic rhinitis, Chronic urticaria. PO (Children 6– 12 mo): 2.5 once daily.
Action Hepatic/Renal Impairment
Antagonizes the effects of histamine at H1-receptor sites; does not bind to or inactivate PO (Adults and Children ⱖ12 yr): CCr ⱕ31 mL/min, hepatic impairment or he-
histamine. Anticholinergic effects are minimal and sedation is dose related. Thera- modialysis— 5 mg once daily.
peutic Effects: Decreased symptoms of histamine excess (sneezing, rhinorrhea, Hepatic/Renal Impairment
ocular tearing and redness, pruritus). PO (Children 6– 11 yr): start therapy at ⬍2.5 mg/day.
Pharmacokinetics Hepatic/Renal Impairment
Absorption: Well absorbed following oral administration. PO (Children ⬍6 yr): use not recommended.
Distribution: Unknown. NURSING IMPLICATIONS
Protein Binding: 93%.
Metabolism and Excretion: Excreted primarily unchanged by the kidneys. Assessment
Half-life: 7.4– 9 hr (pin children to 6.2 hr,qin renal impairment up to 19– 21 ● Assess allergy symptoms (rhinitis, conjunctivitis, hives) before and periodically
hr). during therapy.
● Assess lung sounds and character of bronchial secretions. Maintain fluid intake of
TIME/ACTION PROFILE (antihistaminic effects) 1500– 2000 mL/day to decrease viscosity of secretions.
ROUTE ONSET PEAK DURATION ● Lab Test Considerations: May cause false-negative result in allergy skin test-
PO 30 min 4–8 hr 24 hr ing.

Contraindications/Precautions Potential Nursing Diagnoses


Ineffective airway clearance (Indications)
Contraindicated in: Hypersensitivity to cetirizine, hydroxyzine or any compo- Risk for injury (Adverse Reactions)
nent; Lactation: Excreted in breast milk; not recommended for use.
Use Cautiously in: Patients with hepatic or renal impairment (doseprecom- Implementation
mended if CCr ⱕ31 mL/min or hepatic function is impaired); OB, Pedi: Safety not ● Do not confuse cetirizine with sertraline. Do not confuse Zyrtec (cetiri-
established for pregnant women or children ⬍6 mo; Geri: Initiate at lower doses. zine) with Lipitor (atorvastatin), Zantac (ranitidine), Zocor (simvasta-
⫽ Canadian drug name. ⫽ Genetic Implication. CAPITALS indicate life-threatening, underlines indicate most frequent. Strikethrough ⫽ Discontinued.
Name /bks_53161_deglins_md_disk/cetirizine 02/11/2014 09:37AM Plate # 0-Composite pg 2 # 2

2
tin), Zyprexa (olanzapine), Zyrtec-D (cetirizine/pseudoephedrine), PDF Page #2
Zyrtec Itchy Eye Drops (ketotifen fumarate).
● PO: Administer once daily without regard to food.

Patient/Family Teaching
● Instruct patient to take medication as directed.
● May cause dizziness and drowsiness. Caution patient to avoid driving or other ac-
tivities requiring alertness until response to medication is known.
● Advise patient to avoid taking alcohol or other CNS depressants concurrently with
this drug.
● Advise patient that good oral hygiene, frequent rinsing of mouth with water, and
sugarless gum or candy may minimize dry mouth. Patient should notify dentist if
dry mouth persists ⬎2 wk.
● Instruct patient to contact health care professional if dizziness occurs or if symp-
toms persist.
Evaluation/Desired Outcomes
● Decrease in allergic symptoms.
Why was this drug prescribed for your patient?

䉷 2015 F.A. Davis Company

You might also like